Clinical, Bacteriological and Radiological Study of Community Acquired Pneumonia (CAP)
Authors/Creators
- 1. Senior Resident, Smt. N.H.L. Municipal Medical College, SCL Hospital
- 2. Assistant Professor, Smt. N.H.L. Municipal Medical College, SCL Hospital
- 3. Junior Resident, Smt. N.H.L. Municipal Medical College, SCL Hospital
Description
Pneumonia that develops outside the hospital is considered community acquired Pneumonia (CAP) and is the highest cause of mortality among infectious diseases. The objective of the study is to know Clinical presentation, the prevalence of causative microorganism and to study the Radiological profile of the patients with community acquired pneumonia. This was a prospective study of 100 patients admitted in tertiary care hospital during the period from August 2019 to August 2021. Patients with age more than 12 years and having clinical features like fever (temperature more than 37.8 degree Celsius), cough (less than 4 weeks), production of purulent sputum, chest pain and difficulty in breathing and having Radiological evidence of pneumonia were included in the study. The patients in this study were of more than 12 years. In this study, older age group (>50 year) is more prone to Pneuomnia. The incidence of CAP was most common in males (64%) compared to females(36%). Cough, Fever, Expectoration, Pleuritic chest pain and Dyspnea are common signs present in Community acquired Pneumonia wherease Altered sensorium and Hemoptysis are observed in only few patients. Smoking and COPD are more common associated risk factors. Mortality is less in Community Acquired Pneumonia. Outcome in Community Acquired Pneumonia is good when it is presented and treated timely and accordingly. Most of the patients recovered without any complication except in patients with COPD, symptoms were not completely reduced and were advised for follow-up.
Abstract (English)
Pneumonia that develops outside the hospital is considered community acquired Pneumonia (CAP) and is the highest cause of mortality among infectious diseases. The objective of the study is to know Clinical presentation, the prevalence of causative microorganism and to study the Radiological profile of the patients with community acquired pneumonia. This was a prospective study of 100 patients admitted in tertiary care hospital during the period from August 2019 to August 2021. Patients with age more than 12 years and having clinical features like fever (temperature more than 37.8 degree Celsius), cough (less than 4 weeks), production of purulent sputum, chest pain and difficulty in breathing and having Radiological evidence of pneumonia were included in the study. The patients in this study were of more than 12 years. In this study, older age group (>50 year) is more prone to Pneuomnia. The incidence of CAP was most common in males (64%) compared to females(36%). Cough, Fever, Expectoration, Pleuritic chest pain and Dyspnea are common signs present in Community acquired Pneumonia wherease Altered sensorium and Hemoptysis are observed in only few patients. Smoking and COPD are more common associated risk factors. Mortality is less in Community Acquired Pneumonia. Outcome in Community Acquired Pneumonia is good when it is presented and treated timely and accordingly. Most of the patients recovered without any complication except in patients with COPD, symptoms were not completely reduced and were advised for follow-up.
Files
IJPCR,Vol15,Issue8,Article91.pdf
Files
(378.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:872b08d4d1bcb781719bd41155914459
|
378.1 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-07-25
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue8,Article91.pdf
- Development Status
- Active
References
- 1. Fishman's, Pulmonary disease and Disorders, 5th edition, April 14, 2015, chapter 128, acutebronchitis and community-acquired pneumonia, pn-1966 - 1967,0071807284 2. Halm EA, Teirstein AS: Clinical practice. Management of community acquired pneumonia. New England Journal of Medicine 2002; 347: 2039-2045. 3. Restrepo M.I., Mortensen E.M., Pugh J.A., et al: COPD is associated with increased mortality in patients with community-acquired pneumonia. European Respiratory Journal 2006; 28:346- 351. 4. Mandell LA, Bartlett JG, Dowell SF, File Jr TM, Musher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37: 1405-33. https://www.ncbi. nlm.nih.gov/pmc/articles/PMC7199894/ (June 2020) 5. Fauci (2012). Harrison's Principles of Internal Medicine (18th Edition). New York, USA: McGraw-Hill Professional Publishing. Disorder of Respiratory System, Pneumonia. 6. Patil, et al. Clinical, Bacteriological and Radiological Study of Community Acquired Pneumonia. International Journal of Contemporary Medical Research. July 2019; 6:7. ICV: 98.46. 7. Elisabeth G. W. Huijskens, Marion Koopmans. The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia. Journal of Medical Microbiology 2014; 63, 441–452. 8. Polverino E, Torres A, Menendez R, et al. Thorax. 2013;68:1007–1014. 9. Boonsawat Wipa, Boonma Puntip et al. Community-acquired pneumonia in adults at srinagarind hospital. J med assoc thai. 1990; 73:345- 52.